BCR variable region mutation rate is prognostic in chronic lymphocytic leukemia (Hamblin et al., 1999), and adaptive immune receptor repertoire profiling provides the most sensitive method of detecting minimal residual disease in B-cell leukemias (Logan et al., 2014). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.